Axis-Shield & Abbott Laboratories in drug test deal
This article was originally published in Clinica
Executive Summary
Abbott Laboratories will market and distribute an athletes' drug test to be developed and manufactured by Anglo-Norwegian company Axis-Shield under an agreement reached between the two companies last month. The test will screen athletes for levels of testosterone, abnormally high levels of which can indicate that an athlete is taking banned performance enhancing drugs. It will be used on Abbott's AxSym automated immunoassay testing platform, which combines continuous and random access and STAT capabilities.